Table 1 Networks in which NBS revealed a negative effect of esketamine on dynamic rsFC.

From: Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks

Atlas

Statistic

p-value

Edges

Nodes

Esketamine < placebo

Exponentially weighted sliding-window

Craddock

Extent

0.004

45

36

Craddock

Intensity

0.002

45

36

Power

Extent

0.017

14

10

Power

Intensity

0.003

14

10

Power

Intensity

0.023

5

6

Multiplication of temporal derivatives

Craddock

Extent

0.033

25

19

Craddock

Extent

0.005

57

27

Craddock

Intensity

0.024

25

19

Craddock

Intensity

0.003

57

27

Power

Extent

0.005

23

23

Power

Intensity

0.005

23

23

  1. Illustrates networks elucidated through NBS31. In these networks, regression coefficients between dynamic rsFC time-course and esketamine plasma levels differed significantly between the esketamine and placebo conditions, demonstrating a significant effect of esketamine on dynamic rsFC. All networks were found for the comparison esketamine < placebo.
  2. Edges = number of connections, nodes = number of regions.
  3. Exponentially weighted sliding-window based on Zalesky et al.25, multiplication of temporal derivatives based on Shine et al.26.
  4. Craddock and Power denote parcellations based on Craddock et al.29 and Power et al.30.
  5. Extent and intensity statistics based on NBS31.